Event : Webinar On - Improved Generic Drugs via the 505(b)(2) Regulatory Pathway: FDA Approval Made Easy http://www.rsc.org/events/detail/10366/Webinar%20On%20-%20Improved%20Generic%20Drugs%20via%20the%20505(b)(2)%20Regulatory%20Pathway%3a%20FDA%20Approval%20Made%20Easy This is a feed for event : Webinar On - Improved Generic Drugs via the 505(b)(2) Regulatory Pathway: FDA Approval Made Easy Thu, 11 Sep 2014 13:13:13 +0100 10366 10366 http://www.rsc.org/events/detail/10366/Webinar%20On%20-%20Improved%20Generic%20Drugs%20via%20the%20505(b)(2)%20Regulatory%20Pathway%3a%20FDA%20Approval%20Made%20Easy Webinar On - Improved Generic Drugs via the 505(b)(2) Regulatory Pathway: FDA Approval Made Easy Event dates: 19 February 2014<br/>Event summary: A 505(b)(2) product is an improved or altered version or a new use application for a previously FDA-approved drug. This unique regulatory pathway, available only for marketing approval in the US, of<br/>Event Venue: Online, Mississauga, L5V 2V5, Canada Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00